69.29
price down icon1.63%   -1.15
after-market Handel nachbörslich: 70.67 1.38 +1.99%
loading
Schlusskurs vom Vortag:
$70.44
Offen:
$67.38
24-Stunden-Volumen:
601.85K
Relative Volume:
0.66
Marktkapitalisierung:
$2.50B
Einnahmen:
$117.67M
Nettoeinkommen (Verlust:
$-1.88B
KGV:
-1.1446
EPS:
-60.5369
Netto-Cashflow:
$-621.36M
1W Leistung:
+10.30%
1M Leistung:
+82.15%
6M Leistung:
+178.83%
1J Leistung:
+399.57%
1-Tages-Spanne:
Value
$65.60
$71.59
1-Wochen-Bereich:
Value
$61.50
$75.53
52-Wochen-Spanne:
Value
$12.76
$75.53

Grail Inc Stock (GRAL) Company Profile

Name
Firmenname
Grail Inc
Name
Telefon
(833) 694-2553
Name
Adresse
1525 O'BRIEN DRIVE, MENLO PARK
Name
Mitarbeiter
1,000
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
GRAL's Discussions on Twitter

Vergleichen Sie GRAL mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
GRAL
Grail Inc
69.29 2.54B 117.67M -1.88B -621.36M -60.54
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
525.83 198.09B 43.21B 6.58B 6.17B 17.28
Diagnostics & Research icon
DHR
Danaher Corp
206.15 146.89B 24.01B 3.41B 4.86B 4.7082
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
636.91 50.67B 4.04B 985.66M 774.34M 12.01
Diagnostics & Research icon
A
Agilent Technologies Inc
138.04 39.19B 6.79B 1.22B 1.09B 4.2644
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
204.76 34.64B 15.70B 1.24B 2.01B 6.9036

Grail Inc Stock (GRAL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-21 Eingeleitet Canaccord Genuity Buy
2024-11-27 Eingeleitet Morgan Stanley Equal-Weight
2024-11-15 Eingeleitet Wolfe Research Peer Perform
2024-10-17 Eingeleitet Guggenheim Neutral

Grail Inc Aktie (GRAL) Neueste Nachrichten

pulisher
Oct 13, 2025

Will GRAIL LLC stock deliver better than expected guidance2025 Valuation Update & Trade Opportunity Analysis Reports - newser.com

Oct 13, 2025
pulisher
Oct 12, 2025

Why GRAIL Inc. (NL0) stock could rally strongly2025 Big Picture & Breakout Confirmation Trade Signals - newser.com

Oct 12, 2025
pulisher
Oct 11, 2025

President Joshua Ofman Sold A Bunch Of Shares In GRAIL - simplywall.st

Oct 11, 2025
pulisher
Oct 10, 2025

GRAIL (NASDAQ:GRAL) Hits New 52-Week HighHere's Why - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

The holy grail of modern marketing - Fast Company

Oct 10, 2025
pulisher
Oct 10, 2025

11,400 Shares in GRAIL, Inc. $GRAL Purchased by Trifecta Capital Advisors LLC - MarketBeat

Oct 10, 2025
pulisher
Oct 09, 2025

CRCM LP Reduces Stake in GRAIL Inc.: A Strategic Portfolio Adjustment - GuruFocus

Oct 09, 2025
pulisher
Oct 09, 2025

GRAIL (NASDAQ:GRAL) President Sells $5,086,562.50 in Stock - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

GRAIL (NASDAQ:GRAL) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat

Oct 09, 2025
pulisher
Oct 08, 2025

Recent Developments Impacting GRAL - timothysykes.com

Oct 08, 2025
pulisher
Oct 08, 2025

GRAIL (NASDAQ:GRAL) Trading Up 7.6%Here's Why - MarketBeat

Oct 08, 2025
pulisher
Oct 08, 2025

Do Insider Sales at GRAIL (GRAL) Hint at Shifting Management Confidence Amid Revenue Growth? - simplywall.st

Oct 08, 2025
pulisher
Oct 07, 2025

GRAIL (GRAL): Evaluating Valuation After 20% Revenue Growth and Modest Share Price Gains - Yahoo Finance

Oct 07, 2025
pulisher
Oct 07, 2025

Slow Capital Inc. Raises Stock Holdings in GRAIL, Inc. $GRAL - MarketBeat

Oct 07, 2025
pulisher
Oct 06, 2025

GRAIL (NASDAQ:GRAL) Trading Down 4% Following Insider Selling - MarketBeat

Oct 06, 2025
pulisher
Oct 06, 2025

Liquid Biopsy for Early Cancer Detection and Monitoring - GlobeNewswire

Oct 06, 2025
pulisher
Oct 06, 2025

Liquid Biopsy for Early Cancer Detection and Monitoring Market Report 2025-2033, with Profiles of GRAIL, AnchorDx, Burning Rock Biotech, Genecast, Guardant Health, Elypta, Freenome, and Oncimmune - Yahoo Finance

Oct 06, 2025
pulisher
Oct 05, 2025

Why GRAIL Inc. (NL0) stock stays on top picksTrade Volume Summary & High Accuracy Trade Signal Alerts - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Insider Sell: Joshua Ofman Sells 9,692 Shares of GRAIL Inc (GRAL) - GuruFocus

Oct 03, 2025
pulisher
Oct 03, 2025

Biotech Breakthrough: GRAIL (GRAL) Stock Surges on New Cancer-Detection Data! - ts2.tech

Oct 03, 2025
pulisher
Oct 03, 2025

Grail price target raised to $75 from $43 at Canaccord - TipRanks

Oct 03, 2025
pulisher
Oct 03, 2025

How GRAIL Inc. (NL0) stock trades under stagflationEarnings Overview Report & Fast Gaining Stock Strategy Reports - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

GRAIL (NASDAQ:GRAL) Given New $75.00 Price Target at Canaccord Genuity Group - MarketBeat

Oct 03, 2025
pulisher
Oct 03, 2025

Grail Inc stock hits all-time high of 64.0 USD By Investing.com - Investing.com Nigeria

Oct 03, 2025
pulisher
Oct 02, 2025

Grail Inc stock hits all-time high of 64.0 USD - Investing.com India

Oct 02, 2025
pulisher
Oct 02, 2025

Multi-cancer Detection Tests | MCD | GRAIL Galleri Test - American Cancer Society

Oct 02, 2025
pulisher
Oct 01, 2025

GRAIL Inc Signs New Headquarters Lease Agreement - MSN

Oct 01, 2025
pulisher
Sep 30, 2025

Making Sense of the Numbers: Interpreting Multi-Cancer Early Detection Test Performance - MarketScreener

Sep 30, 2025
pulisher
Sep 30, 2025

GRAIL Inc. (GRAL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Sep 30, 2025
pulisher
Sep 30, 2025

Grail: A Speculative Buy (NASDAQ:GRAL) - Seeking Alpha

Sep 30, 2025
pulisher
Sep 30, 2025

Wealth Enhancement Advisory Services LLC Acquires 6,032 Shares of GRAIL, Inc. $GRAL - MarketBeat

Sep 30, 2025
pulisher
Sep 29, 2025

Will GRAL’s Latest Spike Sustain? - timothysykes.com

Sep 29, 2025
pulisher
Sep 29, 2025

GRAIL (NASDAQ:GRAL) Stock Price Up 7.2%Still a Buy? - MarketBeat

Sep 29, 2025
pulisher
Sep 29, 2025

Why Is GRAIL Stock Rising? - StocksToTrade

Sep 29, 2025
pulisher
Sep 29, 2025

Illumina, Grail Beat Investor Suit Over Doomed Acquisition (2) - Bloomberg Law News

Sep 29, 2025
pulisher
Sep 28, 2025

What drives GRAIL Inc NL0 stock priceCovered Call Writing & Hidden Gems with Outstanding Profit Margins - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

The European Commission prohibits and plans to unwind Illumina's acquisition of GRAIL - Norton Rose Fulbright

Sep 28, 2025
pulisher
Sep 27, 2025

GRAIL, Inc. (GRAL): A Bull Case Theory - MSN

Sep 27, 2025
pulisher
Sep 27, 2025

What drives GRAIL LLC stock priceInsider Buying Signals & Compound Your Gains With Quality Stocks - Early Times

Sep 27, 2025
pulisher
Sep 26, 2025

Illumina And Grail Nix Investor Suit Over Failed Deal, For Now - Law360

Sep 26, 2025
pulisher
Sep 26, 2025

This Cancer Detection Pioneer Is Worth a Look - Yahoo Finance

Sep 26, 2025
pulisher
Sep 26, 2025

Is GRAIL LLC stock attractive after correctionSwing Trade & High Conviction Investment Ideas - newser.com

Sep 26, 2025
pulisher
Sep 26, 2025

Will Rising Galleri Adoption Drive Growth For GRAIL Stock? - RTTNews

Sep 26, 2025
pulisher
Sep 26, 2025

Dakota Wealth Management Makes New Investment in GRAIL, Inc. $GRAL - MarketBeat

Sep 26, 2025
pulisher
Sep 24, 2025

GRAIL to Showcase New Data for Galleri Multicancer Early Detection Test at Key Fall Meetings - Patient Care Online

Sep 24, 2025
pulisher
Sep 24, 2025

GRAIL to Present New Galleri® Data From More Than 32,000 Partici - GuruFocus

Sep 24, 2025
pulisher
Sep 23, 2025

GRAIL to present first PATHFINDER 2 results at ESMO Congress By Investing.com - Investing.com South Africa

Sep 23, 2025
pulisher
Sep 23, 2025

GRAIL to present first PATHFINDER 2 results at ESMO Congress - Investing.com

Sep 23, 2025
pulisher
Sep 23, 2025

GRAIL to Present New Galleri® Data From More Than 32,000 Participants Across the PATHFINDER 2, SYMPLIFY and REFLECTION Studies at ESMO Congress 2025 and EDCC - MarketScreener

Sep 23, 2025

Finanzdaten der Grail Inc-Aktie (GRAL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
diagnostics_research WAT
$333.14
price down icon 0.95%
diagnostics_research DGX
$185.39
price up icon 1.43%
diagnostics_research LH
$279.78
price up icon 1.14%
$172.81
price down icon 0.78%
diagnostics_research MTD
$1,303.04
price up icon 1.42%
diagnostics_research IQV
$204.76
price up icon 0.49%
Kapitalisierung:     |  Volumen (24h):